JOSEPH GURULE: Open Payments
NPI 1396702973 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,080 in 64 payments from 16 companies in 2025. Trend: 2023 $4,366 · 2024 $5,036 · 2025 $2,080
Food & beverage: $2,032Education: $48
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 4 | $272 |
| ABBVIE INC. | 7 | $265 |
| PFIZER INC. | 8 | $209 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $207 |
| Regeneron Healthcare Solutions, Inc. | 4 | $179 |
| Janssen Biotech, Inc. | 8 | $153 |
| Amgen Inc. | 6 | $148 |
| UCB, Inc. | 4 | $130 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $125 |
| Incyte Corporation | 1 | $122 |
Products named: SKYRIZI, NEMLUVIO, CIBINQO, TREMFYA, Otezla, LIBTAYO, Bimzelx, SPEVIGO.
Industry payments across NV — which companies pay providers there.
